Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction: Randomized, placebo-controlled, double-blind study at multicenters

Cerebrovascular Diseases

Volumn 15, Issue 3, 2003, Pages 222-229

  Otomo, Eiichi ^a,b   Tohgi, H ^c   Kogure, K ^d   Hirai, S ^e   Takakura, K ^f   Terashi, A ^g   Gotoh, F ^h   Maruyama, S ⁱ   Tazaki, Y ^j   Shinohara, Y ^k   Ito, E ^l   Sawada, T ^m   Yamaguchi, T ⁿ   Kikuchi, H ^o   Kobayashi, S ^p   Fujishima, M ^q   Nakashima, M ^r  

^a Yokufukai Geriatric Hospital   (Japan)

^b Yokufukai Geriatric Hospital   (Japan)

^c IWATE MEDICAL UNIVERSITY   (Japan)

^d Internal Medicine   (Japan)

^e GUNMA UNIVERSITY   (Japan)

^f TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^g NIPPON MEDICAL SCHOOL   (Japan)

^h KEIO UNIVERSITY   (Japan)

ⁱ Toda Central General Hospital   (Japan)

^j KITASATO UNIVERSITY   (Japan)

^k TOKAI UNIVERSITY   (Japan)

^l NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^m B F Laboratory   (Japan)

ⁿ NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^o KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^p SHIMANE UNIVERSITY   (Japan)

^q KYUSHU UNIVERSITY   (Japan)

^r HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

Acute stroke; Clinical trial; Free radical; Neuroprotection

Indexed keywords

NORPHENAZONE; SCAVENGER;

ACUTE DISEASE; ACUTE KIDNEY FAILURE; ADULT; AGED; ANEMIA; ANXIETY DISORDER; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; EPIGASTRIC PAIN; FEMALE; FEVER; HOSPITAL DISCHARGE; HUMAN; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MOTOR PERFORMANCE; MULTICENTER STUDY; NAUSEA; NEUROPROTECTION; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ANTIPYRINE; CEREBRAL INFARCTION; DOUBLE-BLIND METHOD; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; TREATMENT OUTCOME;

EID: 0037229213     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000069318     Document Type: Article

References (36)

1. Kontos HA: George E Brown memorial lecture. Oxygen radicals in cerebral vascular injury. Circ Res 1985;57:508-516.
2. Schmidley JW: Free radicals in central nervous system ischemia. Stroke 1990;21:1086-1090.
3. Halliwell B: Reactive oxygen species and the central nervous system. J Neurochem 1992;59: 1609-1623.
4. Gaudet RJ, Levine L: Transient cerebral ischemia and brain prostaglandins. Biochem Biophys Res Commun 1979;86:893-901.
5. Moskowitz MA, Kiwak KJ, Hekimian K, Levine L: Synthesis of compounds with properties of leukotrienes C4 and D4 in gerbil brains after ischemia and reperfusion. Science 1984;224:886-889.
6. Asano T, Gotoh O, Koide T, Takakura K: Ischemic brain edema following occlusion of the middle cerebral artery in the rat. II. Alteration of the eicosanoid synthesis profile of brain microvessels. Stroke 1985;16:110-113.
7. Chan PH, Fishman RA, Longar S, Chen S, Yu A: Cellular and molecular effects of polyunsaturated fatty acids in brain ischemia and injury. Prog Brain Res 1985;63:227-235.
8. Watanabe T, Yuki S, Egawa M, Nishi H: Protective effects of MCI-186 on cerebral ischemia: Possible involvement of free radical scavenging and antioxidant actions. J Pharmacol Exp Ther 1994;268:1597-1604.
9. Watanabe T, Morita I, Nishi H, Murota S: Preventive effect of MCI-186 on 15-HPETE induced vascular endothelial cell injury in vitro. Prostaglandins Leukot Essent Fatty Acids 1988;33:81-87.
10. Abe K, Yuki S, Kogure K: Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger. Stroke 1988;19:480-485.
11. Nishi H, Watanabe T, Sakurai H, Yuki S, Ishibashi A: Effect of MCI-186 on brain edema in rats. Stroke 1989;20:1236-1240.
12. Kawai H, Nakai H, Suga M, Yuki S, Watanabe T, Saito K: Effects of a novel free radical scavenger, MCI-186, on ischemic brain damage in the rat distal middle cerebral artery occlusion model. J Pharmacol Exp Ther 1997;281:921-927.
13. Mizuno A, Umemura K, Nakashima M: Inhibitory effect of MCI-186, a free radical scavenger, on cerebral ischaemia following rat middle cerebral artery occlusion. Gen Pharmacol 1998;30:575-578.
14. Yamamoto T, Yuki S, Watanabe T, Mitsuka M, Saito K, Kogure K: Delayed neuronal death prevented by inhibition of increased hydroxyl radical formation in a transient cerebral ischemia. Brain Res 1997;762:240-242.
15. Nakagomi T, Yamakawa K, Sasaki T, Saito I, Takakura K: Effect of edaravone on cerebral vasospasm following experimental subarachnoid hemorrhage. J Stroke Cerebrovasc Dis, in press.
16. Otomo E, Tohgi H, Kogure K, Hirai S, Terashi A, Gotoh F, Tazaki Y, Ito E, Sawada T, Kobayashi S, Fujishima M, Nakashima M: Clinical efficacy of a free radical scavenger, MCI-186, on acute cerebral infarction: Early phase II clinical trial. Ther Res 1998;19:1311-1332.
17. MCI-186 Acute Cerebral Infarction Study Group: Late phase 2 clinical trial of MCI-186 on acute cerebral infarction: A dose-finding double-blind study (in Japanese). J Clin Exp Med 1998;185:841-863.
18. Ohta T, Kikuchi H, Hashi K, Kudo Y: Nizofenone administration in the acute stage following subarachnoid hemorrhage: Results of a multi-center controlled double-blind clinical study. J Neurosurg 1986;64:420-426.
19. Minematsu K, Yamaguchi T, Omae T: Spectacular shrinking deficit: Rapid recovery from a major hemispheric syndrome by migration of an embolus. Neurology 1992;42:157-162.
20. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJA, van Gijn J: Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604-607.
21. Barinaga M: Finding new drugs to treat stroke. Science 1996;272:664-666.
22. Astrup J, Siesjo BK, Symon L: Thresholds in cerebral ischemia: The ischemic penumbra. Stroke 1981;12:723-725.
23. Hossmann KA: Viability thresholds and the penumbra of focal ischemia. Ann Neurol 1994;36:557-565.
24. Fisher M: Characterizing the target of acute stroke therapy. Stroke 1997;28:866-872.
25. Houkin K, Nakayama N, Kamada K, Noujou T, Abe H, Kashiwaba T: Neuroprotective effect of the free radical scavenger MCI-186 in patients with cerebral infarction: Clinical evaluation using magnetic resonance imaging and spectroscopy. J Stroke Cerebrovasc Dis 1998;7:1-9.
26. Yamamoto Y, Kuwahara T, Watanabe K, Watanabe K: Antioxidant activity of 3-methyl-1-phenyl-2-pyrazolin-5-one. Redox Rep 1996;2:333-338.
27. Takamatsu Y, Watanabe T: Studies on the concentrations of 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186) in dog plasma and cerebral spinal fluid. Jpn Pharmacol Ther 1997;25(suppl):1793-1797.
28. Ando K, Nishi H, Watanabe T, Watanabe Y, Yuki S, Sugasawa K, Horii D, Ishibashi A, Kimura A, Nakano D, Morinaga T: General pharmacological studies of 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186), a novel radical scavenging agent. Jpn Pharmacol Ther 1997;25(suppl):1723-1753.
29. Watanabe Y, Watanabe T, Ando K, Yuki S, Saito K, Ishibashi A: Drug interaction between radical scavenger, 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186), and stroke-medicating agents. Jpn Pharmacol Ther 1997;25(suppl):1709-1718.
30. Takamatsu Y, Yuki S, Watanabe T: Studies on the concentrations of 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186) in MCA occlusion and reperfusion model of rats. Jpn Pharmacol Ther 1997;25(suppl):1785-1791.
31. Shibata H, Arai S, Izawa M, Murasaki M, Takamatsu Y, Izawa O, Takahashi C, Tanaka M: Phase I clinical study of MCI-186 (edaravone, 3-methyl-1-phenyl-2-pyrazoline-5-one) in healthy volunteers: Safety and pharmacokinetics of single and multiple administrations. Jpn J Clin Pharmacol Ther 1998;29:863-876.
32. Yokota S, Kumagai Y, Uchiumi M, Isawa S, Murasaki M, Akimoto K, Iwamoto M, Yuasa T, Iwano M: A pharmacokinetic study of MCI-186, a novel drug for cerebrovascular disease in elderly and young healthy subjects. Jpn J Clin Pharmacol Ther 1997;28:693-702.
33. Gotoh O, Koide T, Asano T, Takakura K, Tamura A, Sano K: A model to study ischemic brain edema in rats and the influence of drugs; in Go KG, Baethmann A (eds): Recent Progress in the Study and Therapy of Brain Edema. Plenum Press, 1984, pp 499-508.
34. Matsui T, Mori T, Tateishi N, Kagamiishi Y, Satoh S, Katsube N, Morikawa E, Morimoto T, Ikuta F, Asano T: Astrocytic activation and delayed infarct expansion after permanent focal ischemia in rats. I. Enhanced astrocytic synthesis of s-100β in the periinfarct area precedes delayed infarct expansion. J Cereb Blood Flow Metab 2002;22:711-722.
35. Peters O, Back T, Lindauer U, Busch C, Megow D, Dreier J, Dirnagl U: Increased formation of reactive oxygen species after permanent and reversible middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 1998;18:196-205.
36. Wang PY, Kao CH, Mui MY, Wang SJ: Leukocyte infiltration in acute hemispheric ischemic stroke. Stroke 1993;24:236-240.